Ero sivun ”Senna” versioiden välillä
| Rivi 2: | Rivi 2: | ||
|kuva=Senna.jpg | |kuva=Senna.jpg | ||
|kuvateksti=Senna | |kuvateksti=Senna | ||
| + | |info6=1. Leng-Peschlow E. Dual effect of orally administered sennosides on large intestinal transit and fluid absorption in the rat. J Pharm Pharmacol 1986;38:606–10. | ||
| + | |||
| + | 2. Passmore AP, Davies KW, Flanagan PG, et al. A comparison of Agiolax and Lactulose in elderly patients with chronic constipation. Pharmacol 1993;47(suppl 1):249–52. | ||
| + | |||
| + | 3. Kinnunen O, Winblad I, Koistinen P, Salokannel J. Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients.Pharmacol 1993;47(suppl 1):253–5. | ||
| + | |||
| + | 4. Ewe K, Ueberschaer B, Press AG. Influence of senna, fibre, and fibre+senna on colonic transit in loperamide-induced constipation. Pharmacol 1993;47(suppl 1):242–8. | ||
| + | |||
| + | 5. Valverde A, Hay JM, Fingerhut A, et al. Senna vs polyethylene glycol for mechanical preparation the evening before elective colonic or rectal resection: a multicenter controlled trial. French Association for Surgical Research. Arch Surg 1999;134:514–9. | ||
| + | |||
| + | 6. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. Montvale, NJ: Medical Economics, 1998, 722–4. | ||
| + | |||
| + | 7. Mengs U. Reproductive toxicological investigations with sennosides. Arzneimittelforschung1986;36:1355–8. | ||
| + | |||
| + | 8. Faber P, Strenge-Hesse A. Relevance of rhein excretion into breast milk. Pharmacol1988;36(suppl 1):212–20. | ||
| + | |||
| + | 9. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 204–8. | ||
| + | |||
| + | 10. Vanderperren B, Rizzo M, Angenot L, et al. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005;39:1353–7. | ||
| + | |||
}} | }} | ||
Versio 25. syyskuuta 2013 kello 09.34
Yleistä tietoa
Senna
Vaikutus ja käyttö
Käytössä huomioitavaa
Lähteet
1. Leng-Peschlow E. Dual effect of orally administered sennosides on large intestinal transit and fluid absorption in the rat. J Pharm Pharmacol 1986;38:606–10.
2. Passmore AP, Davies KW, Flanagan PG, et al. A comparison of Agiolax and Lactulose in elderly patients with chronic constipation. Pharmacol 1993;47(suppl 1):249–52.
3. Kinnunen O, Winblad I, Koistinen P, Salokannel J. Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients.Pharmacol 1993;47(suppl 1):253–5.
4. Ewe K, Ueberschaer B, Press AG. Influence of senna, fibre, and fibre+senna on colonic transit in loperamide-induced constipation. Pharmacol 1993;47(suppl 1):242–8.
5. Valverde A, Hay JM, Fingerhut A, et al. Senna vs polyethylene glycol for mechanical preparation the evening before elective colonic or rectal resection: a multicenter controlled trial. French Association for Surgical Research. Arch Surg 1999;134:514–9.
6. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. Montvale, NJ: Medical Economics, 1998, 722–4.
7. Mengs U. Reproductive toxicological investigations with sennosides. Arzneimittelforschung1986;36:1355–8.
8. Faber P, Strenge-Hesse A. Relevance of rhein excretion into breast milk. Pharmacol1988;36(suppl 1):212–20.
9. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 204–8.
10. Vanderperren B, Rizzo M, Angenot L, et al. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005;39:1353–7.